EA201001002A1 - Твердые липидные микрокапсулы, содержащие гормон роста во внутреннем твердом ядре - Google Patents

Твердые липидные микрокапсулы, содержащие гормон роста во внутреннем твердом ядре

Info

Publication number
EA201001002A1
EA201001002A1 EA201001002A EA201001002A EA201001002A1 EA 201001002 A1 EA201001002 A1 EA 201001002A1 EA 201001002 A EA201001002 A EA 201001002A EA 201001002 A EA201001002 A EA 201001002A EA 201001002 A1 EA201001002 A1 EA 201001002A1
Authority
EA
Eurasian Patent Office
Prior art keywords
solid
growth hormones
microcapsules containing
containing growth
internal
Prior art date
Application number
EA201001002A
Other languages
English (en)
Russian (ru)
Inventor
Жоэль РИШАР
Хелен Габриелла Балдассини
Рита Агостинетто
Луиза Де-Анджелис
Франтс Дешамп
Original Assignee
Мерк Патент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Патент Гмбх filed Critical Мерк Патент Гмбх
Publication of EA201001002A1 publication Critical patent/EA201001002A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EA201001002A 2007-12-21 2008-11-21 Твердые липидные микрокапсулы, содержащие гормон роста во внутреннем твердом ядре EA201001002A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07024906 2007-12-21
PCT/EP2008/009849 WO2009080164A1 (en) 2007-12-21 2008-11-21 Solid lipid microcapsules containing growth hormone in the inner solid core

Publications (1)

Publication Number Publication Date
EA201001002A1 true EA201001002A1 (ru) 2011-06-30

Family

ID=40566364

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201001002A EA201001002A1 (ru) 2007-12-21 2008-11-21 Твердые липидные микрокапсулы, содержащие гормон роста во внутреннем твердом ядре

Country Status (15)

Country Link
US (1) US8729015B2 (enExample)
EP (1) EP2231120B1 (enExample)
JP (1) JP5773651B2 (enExample)
KR (1) KR20100103846A (enExample)
CN (1) CN101903014B (enExample)
AR (1) AR069844A1 (enExample)
AT (1) ATE514417T1 (enExample)
AU (1) AU2008340785B8 (enExample)
BR (1) BRPI0821359A2 (enExample)
CA (1) CA2710062C (enExample)
EA (1) EA201001002A1 (enExample)
ES (1) ES2367093T3 (enExample)
IL (1) IL206393A (enExample)
WO (1) WO2009080164A1 (enExample)
ZA (1) ZA201005167B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0821359A2 (pt) 2007-12-21 2015-06-16 Merck Patent Ges Mit Beschränkter Haftung Microcápsulas de lipídeos sólidas contendo hormônio de crescimento no núcleo sólido interno
WO2010017965A2 (en) * 2008-08-11 2010-02-18 Merck Serono S.A. SOLID LIPID MICROCAPSULES CONTAINING hGH
CN102370630B (zh) * 2010-08-11 2014-04-02 中国科学院过程工程研究所 重组人生长激素rhGH长效缓释微囊及其制备方法
ES2810003T3 (es) 2011-11-18 2021-03-08 Regeneron Pharma Micropartícula que contiene proteína terapéutica recubierta con polímero biodegradable para uso médico
JP6554493B2 (ja) 2014-06-24 2019-07-31 ザ・トラスティーズ・オブ・プリンストン・ユニバーシティＴｈｅ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｐｒｉｎｃｅｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ 可溶性生物製剤、治療薬およびイメージング剤をカプセル化するためのプロセス
KR101602138B1 (ko) 2014-11-21 2016-03-10 강원대학교산학협력단 염화칼슘 미세입자가 봉입된 온도 의존성 고체지질입자 및 그 제조방법
US11103461B2 (en) 2015-12-22 2021-08-31 The Trustees Of Princeton University Process for encapsulating soluble biologics, therapeutics, and imaging agents
KR20170079409A (ko) * 2015-12-30 2017-07-10 한미약품 주식회사 지속형 인간 성장 호르몬 결합체의 신규 액상 제제
CN109380730B (zh) * 2017-08-09 2023-02-03 内蒙古伊利实业集团股份有限公司 微胶囊油脂及其制备方法
WO2019055539A1 (en) 2017-09-12 2019-03-21 Prudhomme Robert K CELLULOSIC POLYMER NANOPARTICLES AND METHODS OF FORMING THE SAME
JP2021501753A (ja) 2017-11-03 2021-01-21 ザ・トラスティーズ・オブ・プリンストン・ユニバーシティＴｈｅ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｐｒｉｎｃｅｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ 徐放性ナノキャリア製剤を形成するための疎水性イオン対化およびフラッシュナノ沈殿
US12186436B2 (en) 2018-07-19 2025-01-07 The Trustees Of Princeton University Triblock copolymer stabilizers for the formation of nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents
US11731099B2 (en) 2018-07-20 2023-08-22 The Trustees Of Princeton University Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation
US20200147032A1 (en) 2018-11-14 2020-05-14 Robert K. Prud'homme Dihydromyricetin hot melt extrusion formulations and methods for forming them
CN114240934B (zh) * 2022-02-21 2022-05-10 深圳大学 一种基于肢端肥大症的图像数据分析方法及系统
CN116571178A (zh) * 2023-05-11 2023-08-11 仲恺农业工程学院 一种蓝莓花色苷微胶囊的制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6068044A (ja) * 1983-09-24 1985-04-18 Tetsuo Kato 二重膜構造のマイクロカプセル
ATE90203T1 (de) * 1989-03-17 1993-06-15 Pitman Moore Inc Kontrollierte, verzoegerte wirkstofffreisetzung von makromolekularen proteinen.
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
AU2001257359A1 (en) * 2000-04-27 2001-11-07 Verion Inc. Zero order release and temperature-controlled microcapsules and process for the preparation thereof
US6967028B2 (en) * 2000-07-31 2005-11-22 Mainelab Prolonged release microspheres for injectable administration
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
EP1595549A4 (en) * 2003-02-19 2010-09-22 Takeda Pharmaceutical DISPERSE FOR PREPARATIONS WITH DELAYED RELEASE
PL2040682T3 (pl) * 2006-06-05 2018-01-31 Dsm Nutritional Products Ag Mikrokapsułki o ulepszonych otoczkach
BRPI0821359A2 (pt) 2007-12-21 2015-06-16 Merck Patent Ges Mit Beschränkter Haftung Microcápsulas de lipídeos sólidas contendo hormônio de crescimento no núcleo sólido interno

Also Published As

Publication number Publication date
AU2008340785A1 (en) 2009-07-02
EP2231120A1 (en) 2010-09-29
EP2231120B1 (en) 2011-06-29
CA2710062C (en) 2016-05-31
WO2009080164A1 (en) 2009-07-02
ES2367093T3 (es) 2011-10-28
CN101903014A (zh) 2010-12-01
CA2710062A1 (en) 2009-07-02
ZA201005167B (en) 2011-03-30
JP2011506499A (ja) 2011-03-03
IL206393A (en) 2015-06-30
BRPI0821359A2 (pt) 2015-06-16
AR069844A1 (es) 2010-02-24
CN101903014B (zh) 2014-04-16
ATE514417T1 (de) 2011-07-15
US20100310649A1 (en) 2010-12-09
AU2008340785B2 (en) 2014-05-08
US8729015B2 (en) 2014-05-20
IL206393A0 (en) 2010-12-30
AU2008340785B8 (en) 2014-09-18
JP5773651B2 (ja) 2015-09-02
KR20100103846A (ko) 2010-09-28

Similar Documents

Publication Publication Date Title
EA201001002A1 (ru) Твердые липидные микрокапсулы, содержащие гормон роста во внутреннем твердом ядре
WO2007117509A3 (en) High delivery rates for lipid based drug formulations, and methods of treatment thereof
EA200601761A1 (ru) Композиции в качестве адъювантов для усиления иммунных ответов на вакцины и способы их применения
TW200806318A (en) Uses of anti-insulin-like growth factor I receptor antibodies
NO20075136L (no) Nye liposompreparater
MX2009002314A (es) Composiciones farmaceuticas que comprenden hgh para suministro oral.
BRPI0406605B8 (pt) conjugado de proteína, método para a preparação do mesmo e composição farmacêutica para intensificar a duração e estabilidade in vivo de um polipeptídeo fisiologicamente ativo
MY188825A (en) High-concentration monoclonal antibody formulations
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
HRP20060147B1 (hr) Terapijski sustav s kontroliranim otpuštanjem za nazalnu primjenu
MX2009001412A (es) Vacunas de matriz de proteinas y metodos de hacer y administrar tales vacunas.
ATE494889T1 (de) Pharmazeutische kombination mit 3- (3- dimethylamino-1-ethyl-2-methyl-propyl)-phenol und paracetamol
EA201101706A1 (ru) Лекарственное средство на основе дииндолилметана(dim) с повышенной биодоступностью и его использование в лечении гиперпластических и воспалительных заболеваний человека
JP2013533268A5 (enExample)
NZ606993A (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
WO2008109119A3 (en) Wnt compositions and methods of use thereof
JP2016539921A5 (enExample)
EA201101596A1 (ru) Композиция для непрерывной доставки лекарственного средства, содержащая геополимерное связующее
EA201101565A1 (ru) Способы введения и составы для лечения регионарной жировой ткани
PL2043637T3 (pl) Sposoby i leki do podawania ibuprofenu
TW200833367A (en) Pharmaceutical compositions and method for treating inflammation in cattle and other animals
ES2570774T3 (es) Uso de ácido araquidónico para reducir el riesgo de resistencia a la insulina más adelante en la vida
EA200501821A1 (ru) Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат
WO2004112838A3 (en) Codrugs of diclofenac
EA201100831A1 (ru) Пять кристаллических форм xlf-iii-43, способы их получения, фармацевтические композиции на их основе и применение